secwatch.observer — SEC 8-K summary
======================================

Issuer:     ICU MEDICAL INC/DE (ICUI)
CIK:        0000883984
Form:       8-K
Filed at:   2025-02-27T23:59:59+00:00
Accession:  0000883984-25-000006
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ICU Medical Q4 2024 revenue up 7% to $629.8M; adj. EPS $2.11 vs $1.57
---------------------------------------------------------------------

- Revenue $629.8M (+7% YoY); GAAP gross margin improved to 36.1% from 29.2%.
- GAAP net loss $(23.8)M ($(0.97)/share) vs $(17.1)M loss ($(0.71)) in Q4 2023.
- Adjusted diluted EPS $2.11 vs $1.57 YoY; Adjusted EBITDA $105.5M vs $86.3M.
- Company provided fiscal year 2025 guidance (detailed numbers not in excerpt).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883984/000088398425000006/0000883984-25-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883984/000088398425000006/icui-20250227.htm
  HTML page:      https://secwatch.observer/filing/0000883984-25-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer